机构:[1]Department of Gastroenterology, The Fourth Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650021, P.R. China.[2]Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive Diseases, Kunming, Yunnan 650032, P.R. China.内科科室外科科室消化内科普通外科普通外一科(胃肠与疝外科)昆明医科大学附属第一医院[3]Department of Medical Oncology, The Fourth Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650021, P.R. China.[4]Department of Gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.外科科室普通外科普通外一科(胃肠与疝外科)昆明医科大学附属第一医院
第一作者机构:[1]Department of Gastroenterology, The Fourth Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650021, P.R. China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhang Yinghui,Dong Xiangqian,Bai Liping,et al.MUC1-induced immunosuppression in colon cancer can be reversed by blocking the PD1/PDL1 signaling pathway.[J].ONCOLOGY LETTERS.2020,20(6):doi:10.3892/ol.2020.12180.
APA:
Zhang Yinghui,Dong Xiangqian,Bai Liping,Shang Xueqin&Zeng Yujian.(2020).MUC1-induced immunosuppression in colon cancer can be reversed by blocking the PD1/PDL1 signaling pathway..ONCOLOGY LETTERS,20,(6)
MLA:
Zhang Yinghui,et al."MUC1-induced immunosuppression in colon cancer can be reversed by blocking the PD1/PDL1 signaling pathway.".ONCOLOGY LETTERS 20..6(2020)